.25 semaglutide Oral Wegovy approved for obesity management by FDA on December 23, 2025 Formulation: High‑dose oral (25 mg daily) — previously only available as weekly injections. Indication: Adults with obesity (BMI ≥30) and reduced Semgo 14mg (Semaglutide) – Advanced

About the author: GLP-1 medications like Ozempic, Mounjaro, and Wegovy have revolutionized weight loss treatment, offering unprecedented success rates for patients struggling with obesity and metabolic dysfunction

In the SURMOUNT-5 head-to-head trial, tirzepatide produced 20.2% loss versus 13.7% for semaglutide

Chicken Breast + Premade Salad 6 min 36g protein ~350 cal Ingredients: 1 Tyson grilled chicken breast (frozen, microwave 2 min) + 1 bag premade salad (Dole or Taylor Farms)

No published trial has tested this specific combination, so the recommendation is extrapolated from known physiology

How does Delivery Channel shape demand